USPTO serial 86734813
DDLD
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 16, 2017
- Examiner
- KING, LINDA M
- Law office
- —
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with DDLD?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Cynthia A. Moyer
Cynthia A. Moyer Fredrikson & Byron, P.A.60 South Sixth StreetSuite 1500Minneapolis, MN 55402Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | [ Inventory management services in the field of pharmaceuticals, namely, monitoring and managing the levels of stock of particular pharmaceutical products for third parties; wholesale distributorships featuring pharmaceutical products; wholesale distributorships featuring pharmaceutical products for use in clinical trials; business auditing services for pharmaceutical manufacturing companies; compilation of statistical data for use in scientific research; compilation of statistical data relating to medical research; provision of business statistical information relating to medical matters; procurement, namely, purchasing pharmaceutical products for others; computerized online ordering services for third parties in the field of pharmaceutical, veterinary and sanitary preparations and medical supplies; retail or wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies ] | SECTION 8 - CANCELLED | — |
| 039 | Delivery of pharmaceutical products; storage of pharmaceutical products; warehousing of pharmaceutical products; distribution services, namely, delivery of pharmaceutical products; advisory services relating to the packaging of goods; advisory services relating to the repackaging of goods; advisory services relating to the storage of goods; bulk storage of goods; packaging articles for transportation; packaging articles to the order and specification of others | ACTIVE | — |
| 042 | [ Testing, analysis and evaluation of the goods of others to determine conformity with certification standards in the field of pharmaceutical manufacturing; design of labels for others for use in clinical testing programs; conducting clinical trials for others in the field of pharmaceutical products; project management of clinical trials for others in the field of pharmaceutical products; product testing, authentication and quality control services for others in the field of clinical trials for pharmaceutical products; analytical scientific laboratory services; quality control for others; medical and scientific research, namely, conducting clinical trials for others; product testing for quality control; testing, analysis, and evaluation of pharmaceuticals to assure compliance with industry standards; inspection of pharmaceuticals; scientific laboratory services; product research and development services; testing, analysis and evaluation of the goods and services of others to determine conformity with certification standards; testing of pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; consultancy in the field of pharmaceutical research; consultancy pertaining to pharmacology; consultancy relating to scientific laboratory services; consultancy relating to scientific research and development in the field of therapeutics; development of pharmaceutical preparations and medicines; information technology consulting services for pharmaceutical and healthcare industries; laboratory research services relating to pharmaceuticals; medical laboratory services; medical research; pharmaceutical drug development services; pharmaceutical products development; pharmaceutical research and development; pharmaceutical research services; providing medical and scientific research information in the field of clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; provision of information relating to medical and veterinary product research and development; research and development of vaccines and medicines; scientific research in the field of pharmacy; pharmaceutical research services for assessing the efficiency of pharmaceuticals ] | SECTION 8 - CANCELLED | — |
| 044 | [ Medical services; provision of advice in relation to the use of pharmaceutical products; advisory services relating to pharmaceuticals; consultancy and information services provided via the Internet relating to pharmaceutical products; consultancy and information services relating to pharmaceutical products; dispensing of pharmaceuticals; pharmaceutical advice; preparation and dispensing of medications; providing of information relating to the preparation and dispensing of medications; provision of information relating to medicine; provision of pharmaceutical information ] | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CLINIGEN HEALTHCARE LIMITED
- Other trademarks owned by CLINIGEN HEALTHCARE LIMITED
- Other trademarks owned by CLINIGEN HEALTHCARE LIMITED
- Other trademarks in Class 035
- Other trademarks in Class 039
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named DDLD
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 16, 2026 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Apr 3, 2024 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Apr 3, 2024 | C15P | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Apr 3, 2024 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Feb 16, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 16, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Feb 16, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 16, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 13, 2023 | PR23 | POST REGISTRATION ACTION MAILED - SEC. 8 & 15 | — |
| Nov 13, 2023 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 21, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 21, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 21, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 15, 2023 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Sep 1, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 1, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 1, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 16, 2022 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| May 16, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 30, 2017 | CORV | REVIEW OF CORRESPONDENCE COMPLETE | — |
| Jan 26, 2017 | APET | ASSIGNED TO PETITION STAFF | — |
| Dec 28, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 28, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 9, 2016 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Dec 5, 2016 | OTHE | CASE RETURNED TO EXAMINATION | — |
| Dec 5, 2016 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Jun 7, 2016 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 12, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 12, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 23, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 10, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 8, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 7, 2016 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 7, 2016 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 7, 2016 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 7, 2016 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 1, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 1, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 24, 2016 | ALIE | ASSIGNED TO LIE | — |
| Feb 17, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 14, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 14, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 14, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 7, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 27, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 27, 2015 | NWAP | NEW APPLICATION ENTERED | — |